title: Chronic obstructive pulmonary disease and lung cancer: common pathogenesis, shared clinical challenges.
abstract: Environmental inhaled noxious particles have been known to play a role in several lung diseases, including chronic obstructive pulmonary disease (COPD) and lung cancer, the deadliest malignancy in the world in both sexes. Of the known noxious agents, tobacco smoking is the leading preventable cause of death worldwide and is a recognized risk for the development of both diseases. The association between COPD and lung cancer has been demonstrated in population-based studies, lung cancer screening programs, epidemiological surveys, and case control and biological mechanistic studies. There is evidence that cumulative smoking history is associated with the risk of developing lung cancer and COPD; however, the majority of smokers do not develop clinical COPD or lung cancer. This suggests the presence of one or several factors that modulate the responses to the offending agents and define the final risk for disease development. The 54th Aspen Lung Conference was convened to provide a forum for a systematic dissection of the potential mechanisms by which persons exposed to the causative agents are able to handle and control the process or, in the case of dysfunctional response, the mechanisms that take off in different directions and result in injury and disease. This summary reviews the themes presented and attempts to integrate them for those clinicians and researchers interested in these topics. The challenges and future directions emanating from the discussions may help frame future conferences and hopefully inspire the interest of young researchers.
authors.affiliation: Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA. bcelli@partners.org
authors.forename: Bartolome R
authors.initials: BR
authors.lastname: Celli
mesh_terms: D003226:Congresses as Topic; D004781:Environmental Exposure / Q000009:adverse effects; D006801:Humans; D007249:Inflammation / Q000209:etiology*; D008175:Lung Neoplasms / Q000209:etiology* / Q000235:genetics / Q000628:therapy; D029424:Pulmonary Disease, Chronic Obstructive / Q000209:etiology* / Q000235:genetics / Q000628:therapy; D012907:Smoking / Q000009:adverse effects*